# Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor–experienced adult patients with PNH: the 302 study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/ravulizumab-alxn1210-vs-eculizumab-in-c5-inhibitor-experienced-adult-patients/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Austin Kulasekararaj,Anita Hill,Scott T. Rottinghaus,Saskia Langemeijer,Richard A. Wells,Fernando González-Fernández,Anna Gayà,Jong Wook Lee,Emilio Ojeda Gutierrez,Caroline Piatek,Jeff Szer,Antonio M. Risitano,Shinji Nakao,Eric Bachman,Lori Shafner,Andrew I. Damokosh,Stephan Ortiz,Alexander Röth,Régis Peffault de Latour |
| Citations | 378 |
| DOI | 10.1182/blood-2018-09-876805 |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://ashpublications.org/blood/article-pdf/133/6/540/1750573/blood876805.pdf |
| OpenAlex ID | https://openalex.org/W2902552969 |
| PMID | 30510079 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Shinji Nakao](https://scholariq.org/researchers/shinji-nakao/)

## Paper journal

- [Blood](https://scholariq.org/journals/blood/)

## Paper primary topic

- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)

## Paper topics

- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Adenosine and Purinergic Signaling](https://scholariq.org/topics/adenosine-and-purinergic-signaling/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.